2.010 hasil
Menampilkan 1–20 · 0,49 detik · RSS
The International Journal of Biological Markers
Scopus
ISSN 1724-6008 · SAGE Publishing · 2.010 artikel di indeks
-
Artikel Jurnal
Molecular biomarkers for early-stage hepatocellular carcinoma: Clinical applications beyond alpha-fetoprotein
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related death worldwide, owing to late-stage diagnosis and underlying liver disease that limits curative treatment options. Conventional surveillance and diagnostic strategies relying on imaging and alpha-fetoprotein (AFP) lack…
-
Artikel Jurnal
Luminex assay of plasma IL-6, TNF-α, leptin, and adiponectin: Impact of anticoagulants, single-well analysis, and freeze–thaw stability
Background Chronic inflammation from visceral obesity contributes to metabolic disorders and cancer through cytokine imbalance. Accurate cytokine measurement is crucial to understand these links. This study examined challenges in quantifying interleudin-6 (IL-6), tumor necrosis factor-alpha…
-
Artikel Jurnal
Association of NF-kappaBIA rs696 gene polymorphism with breast cancer risk in Bangladeshi women: A case-control study
Background Breast cancer is the leading cause of cancer-related mortality among women in developing nations. NFKBIA encodes the inhibitors of nuclear factor-kappaB (NF-κB), which plays a critical role in modulating inflammation and carcinogenic processes. However, no prior studies were conducted to…
-
Artikel Jurnal
Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions
Liquid biopsy has emerged as a powerful approach for non-invasive cancer monitoring, with circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) representing biologically distinct yet complementary analytes. Cell-free DNA (cfDNA) refers to fragmented DNA released into circulation from…
-
Artikel Jurnal
Multigene testing to guide clinical adjuvant decisions in breast cancer: An overview focused on the assessment of the quality of evidence with the grading of recommendations assessment, development and evaluation (GRADE) approach
Multigene tests have emerged as valuable tools in guiding adjuvant chemotherapy decisions for patients with ER-positive/HER2-negative early breast cancer. This study applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the quality of evidence…
-
Artikel Jurnal
Integrative genetic and transcriptomic analyses prioritize CDC16 as a candidate marker for gastric cancer
Background Gastric cancer (GC) remains a major cause of cancer-related mortality, and biomarkers for early detection are needed. Methods Stomach and blood expression quantitative trait loci were integrated with two GC genome-wide association studies using Mendelian randomization (MR), Bayesian…
-
Artikel Jurnal
Single-cell multi-omics reveals NUF2 as a potential biomarker associated with the high-lactylation malignant state in osteosarcoma
Background Lactylation has emerged as a crucial post-translational modification that influences oncogenesis and tumor progression. However, its intratumoral heterogeneity in osteosarcoma is not well characterized. Methods Single-cell multi-omics data were retrieved from the Gene Expression Omnibus…
-
Artikel Jurnal
Concordance of PD-1 expression on paired peripheral and bone marrow T cells: Surrogate potential and clinical implications in DLBCL
Background The PD-1/PD-L1 axis represents a key mechanism of tumor immune evasion. However, its expression across different immune compartments and clinical implications in DLBCL patients remain unclear. Methods This study included 67 newly diagnosed DLBCL patients and 59 healthy controls. The…
-
Artikel Jurnal
PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancer
Background Phosphofructokinase-platelet (PFKP) is a rate-limiting enzyme in glycolysis. PFKP is highly expressed across many cancer types including breast cancer. Purpose To assess the extent to which PFKP can be a prognostic indicator in breast cancer and its ability to predict treatment response…
-
Artikel Jurnal
The diagnostic and predictive value of miR-145-3p in gastric cancer and its regulation of gastric cancer progression via targeting CREB1
Background Gastric cancer (GC) is a highly prevalent malignant tumor worldwide. Traditional treatment approaches have numerous limitations, and messenger RNA (mRNA)-targeted therapy offers a new direction for the treatment of GC. Objective To investigate the expression characteristics and clinical…
-
Artikel Jurnal
A three-miRNA panel in serum: Serving as a novel diagnostic method for nasopharyngeal carcinoma
Background Nasopharyngeal carcinoma has unique epidemiological characteristics. Screening for this currently lacks a highly efficient, non-invasive, and inexpensive method. Serum microRNA (miRNA), which is stable and commonly present, has the potential to serve as a novel marker for nasopharyngeal…
-
Artikel Jurnal
SH3GL1 mediates B7-H3 recycling and enhances the immune escape in non-small cell lung cancer
Purpose This study aimed to investigate the role of SH3GL1 in regulating B7-H3 expression and its impact on immune escape in non-small cell lung cancer (NSCLC). Methods SH3GL1 and B7-H3 expression levels were analyzed in The Cancer Genome Atlas datasets and NSCLC cell lines using quantitative…
-
Artikel Jurnal
Histone deacetylase in human sarcomas
Increasing evidence showed that altered histone deacetylases ( HDACs ) are involved in, and exert cell type specific roles in sarcomagenesis. Here we reviewed expression and roles of HDACs in several types of human sarcomas, providing a basic guideline for personalized therapy. In sarcomas…
-
Artikel Jurnal
Type IV collagen, carcinoembryonic antigen, osteopontin, and hepatocyte growth factor as biomarkers for liver metastatic colorectal cancer
Introduction Diagnosis and monitoring of metastatic colorectal cancer (mCRC) depend on diagnostic imaging. Circulating carcinoembryonic antigen (CEA) can be analyzed but no optimal, non-invasive biomarker exists. Circulating collagen IV (COL IV) is a promising biomarker in patients with colorectal…
-
Artikel Jurnal
Plasma matrix metalloproteinases 7 and 8 and tissue inhibitor of metalloproteinases 1 as prognostic biomarkers in colorectal cancer
Introduction Matrix metalloproteinases (MMPs) are enzymes participating in tumorigenesis and tumor progression through their proteolytic and cell-signaling properties. They are regulated mostly by endogenous tissue inhibitors of metalloproteinases (TIMPs). The expression of both MMPs and TIMPs is…
-
Artikel Jurnal
Prognostic value of clinicopathological features of diffuse large B-cell lymphoma with bone marrow involvement
Background Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. The aim of this study was to comprehensively analyze the clinical, cytomorphological, and flow cytometry characteristics of DLBCL patients, with a focus on bone marrow involvement (BMI), to identify…
-
Artikel Jurnal
Immunogenetic contribution of the / axis in oral squamous cell carcinoma
Oral squamous cell carcinoma (OSCC) is a malignant neoplasm with high mortality and recurrence. Its etiology is multifactorial and involves environmental factors such as smoking, alcohol, and human papilloma virus infection, as well as genetic factors such as single nucleotide polymorphisms. The…
-
Artikel Jurnal
LncRNA PGM5-AS1 regulates cell functions and acts as a potential biomarker to predict prognosis in breast cancer
Background The aggressive proliferation and spread of breast cancer contributes to a dismal clinical outcome. The present study was to investigate the function and underlying mechanism of the long non-coding RNA (lncRNA) PGM5-AS1 in the modulation of breast cancer. Methods Quantitative real…
Menampilkan maksimal 50 halaman. Persempit pencarian dengan filter untuk hasil yang lebih spesifik.